Thursday, April 30, 2009

Robot-Assisted Prostatectomy—The Best Treatment for Prostrate Cancer

The continuous growth of the cells in the prostrate without any deaths causes the condition of the Prostrate Cancer. Various treatments are available as the methodological cures of the prostrate cancer. External beam radiation therapy (EBRT), radioactive seed implants, hormone therapy, Radical prostatectomy, Chemotherapy, and Cryotherapy are the treatments available to cure prostrate cancer. But, the best treatment is considered to be as the robot-assisted prostatectomy. The success rate of the robot-assisted prostatectomy is more than 80% than is much more than all other prostrate cancer treatments. Even the side effects caused by the robot-assisted prostatectomy are very less in comparison to other treatments used to cure prostrate cancer.

Robot-assisted prostatectomy is the process through which the prostrate is removed when it becomes cancerous. Robot-assisted prostatectomy is a minimally invasive way to perform the same surgery using state-of-the art technology. Prostrate is about the size of the walnut and is located below the below the bladder and surrounds the urethra. Before the robot-assisted prostatectomy the tests like digital rectal exam, prostrate-specific antigen test, transrectal ultrasound are performed to understand the stage of the prostrate cancer and how much dangerous is it. After this tests the surgeon decides about that when the person can undergo the robot-assisted prostatectomy. It is only after the doctor takes the proper permission from the patient to remove prostrate from his body.

Robot-assisted prostatectomy is the performed in two procedures that are traperitoneal and transperitoneal. The extraperitoneal prostatectomy does not cut through this membrane, while the transperitoneal prostatectomy does. For this process, the 5 minute incisions are made in the abdomen, which are 1 cm in width. Through these incisions the doctor inserts tube-like instruments, including a long, slender tube with a small camera on the end (laparoscope). This creates a magnified view of the surgical area. The instruments are attached to a mechanical device, and the surgeon sits at a console and guides the instruments through a viewing device to perform the surgery.

The surgeon uses the robot to reduce incision size and for greater precision during surgery. The patient will then have less blood loss, decreased risk of infection, less pain, and a shorter hospital stay. The robot that “performs” the surgery consists of the surgeon console, the display system, the master arms, the control panel, the central processing unit, and the robotic arms. The robot-assisted prostatectomy is found to be beneficial for both patient as well as the surgeon. The main advantage of surgery is that it offers the most certain treatment. That is, if all of the cancer is removed during surgery, you are probably cured. Also, the surgery provides your doctor with accurate information about how advanced your cancer is, since the nearby lymph nodes are taken out along with the tumor.

Robot-assisted prostatectomy is the easiest method to cure the prostrate cancer completely. Patient has to stay in the hospital for about 2 to 7 days when he undergoes the traditional open prostatectomy, while a patient undergoing robot-assisted prostatectomy can go home in a day. With the robot-assisted prostatectomy you get active within a week and you can enjoy the normal life after a month. This treatment is found to be fastest and finest treatment to overcome prostrate cancer. The best thing with the robot-assisted prostatectomy is that you experience very less side effects in comparison to other prostrate cancer treatments. Impotence or erectile dysfunction is the most common side effect of the prostrate cancer treatments, but with the help of the robot-assisted prostatectomy you may enjoy the proper functioning of your penis just after a month. So, please ask your doctor to about the robot-assisted prostatectomy treatment if you are suffering with prostrate cancer.

For more articles see : Netpharma World Blog

No comments: